Matthew Camiolo

ORCID: 0000-0002-9085-6552
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Protein Degradation and Inhibitors
  • Asthma and respiratory diseases
  • Immune Cell Function and Interaction
  • IL-33, ST2, and ILC Pathways
  • Advanced biosensing and bioanalysis techniques
  • Epigenetics and DNA Methylation
  • Histone Deacetylase Inhibitors Research
  • Immune cells in cancer
  • RNA Interference and Gene Delivery
  • CCD and CMOS Imaging Sensors
  • RNA Research and Splicing
  • Telomeres, Telomerase, and Senescence
  • Inhalation and Respiratory Drug Delivery
  • RNA modifications and cancer
  • Single-cell and spatial transcriptomics
  • GaN-based semiconductor devices and materials
  • COVID-19 Clinical Research Studies
  • Genomics and Chromatin Dynamics
  • Cancer-related Molecular Pathways
  • Inflammasome and immune disorders
  • Gene Regulatory Network Analysis
  • Cancer Immunotherapy and Biomarkers
  • Pluripotent Stem Cells Research
  • SARS-CoV-2 and COVID-19 Research
  • Gene expression and cancer classification

Vertex Pharmaceuticals (United States)
2023

UPMC Health System
2019-2022

University of Pittsburgh Medical Center
2021

University of Pittsburgh
2019-2021

Pulmonary and Allergy Associates
2021

Emory University
2020

Stony Brook University
2011-2016

Cold Spring Harbor Laboratory
2010-2014

Cancer Center at Cold Spring Harbor Laboratory
2014

Stony Brook University Hospital
2011

The epidermal growth-factor receptor (EGFR) tyrosine kinase inhibitor erlotinib has been proven to be highly effective in the treatment of nonsmall cell lung cancer (NSCLC) harboring oncogenic EGFR mutations. majority patients, however, will eventually develop resistance and succumb disease. Recent studies have identified secondary mutations (EGFR T790M) amplification N-Methyl-N′-nitro-N-nitroso-guanidine (MNNG) HOS transforming gene (MET) oncogene as two principal mechanisms acquired...

10.1073/pnas.1009472107 article EN Proceedings of the National Academy of Sciences 2010-08-16

Oncogene-induced senescence is a potent barrier to tumorigenesis that limits cellular expansion following certain oncogenic events. Senescent cells display repressive chromatin configuration thought stably silence proliferation-promoting genes while simultaneously activating an unusual form of immune surveillance involving secretory program referred as the senescence-associated phenotype (SASP). Here, we demonstrate also involves global remodeling enhancer landscape with recruitment reader...

10.1158/2159-8290.cd-16-0217 article EN Cancer Discovery 2016-04-21

Significance p53 is one of the most intensively studied tumor-suppressor genes. We identified a naturally occurring isoform, generated by an alternative-splicing event, that, although lacking transcriptional activity and canonical tumor suppressor functions, able to reprogram cells toward acquisition metastatic features via cyclophilin D interaction in mitochondria matrix. Interestingly, this isoform expressed on tissue injury tumors characterized increased spread. In some these tumors,...

10.1073/pnas.1321640111 article EN Proceedings of the National Academy of Sciences 2014-07-29

Clinical definitions of asthma fail to capture the heterogeneity immune dysfunction in severe, treatment-refractory disease. Applying mass cytometry and machine learning bronchoalveolar lavage (BAL) cells, we find that corticosteroid-resistant patients cluster largely into two groups: one enriched interleukin (IL)-4+ innate cells another dominated by interferon (IFN)-γ+ T including tissue-resident memory cells. In contrast, BAL a healthier population are IL-10+ macrophages. To better...

10.1016/j.celrep.2021.108974 article EN cc-by-nc-nd Cell Reports 2021-04-01

Noncoding RNAs play important roles in various aspects of gene regulation. We have identified 7SK RNA to be enriched nuclear speckles or interchromatin granule clusters (IGCs), a subnuclear domain pre-mRNA processing factors. RNA, association with HEXIM 1 and 2, is involved the inhibition transcriptional elongation by polymerase II. Inhibition occurs via sequestration active P-TEFb kinase complex (CDK 9 Cyclin T1/T2a/b K) that phosphorylating C-terminal Our results demonstrate knock-down...

10.1091/mbc.e10-02-0105 article EN Molecular Biology of the Cell 2010-09-30

Asthma is a common disease with profoundly variable natural history and patient morbidity. Heterogeneity has long been appreciated, much work focused on identifying subgroups of patients similar pathobiological underpinnings. Previous studies the Severe Research Program (SARP) cohort linked gene expression changes to specific clinical physiologic characteristics. While invaluable for hypothesis generation, these data include extensive candidate lists that complicate target identification...

10.1172/jci.insight.149945 article EN cc-by JCI Insight 2021-09-30
Abhaya Trivedi Chase Hall Charles W. Goss Daphne Lew J.G. Krings and 95 more M.C. McGregor M. Samant Jered Sieren Huashi Li Ken B. Schechtman Joshua Schirm Stephen McEleney S. Peterson Wendy C. Moore Eugene R. Bleecker Deborah A. Meyers Elliot Israel George R. Washko Bruce D. Levy Joseph K. Leader Sally E. Wenzel John V. Fahy Mark L. Schiebler Sean B. Fain Nizar N. Jarjour David T. Mauger Joseph M. Reinhardt John D. Newell Eric A. Hoffman Mario Castro Ajay Sheshadri Elliot Israel Bruce D. Levy Manuela Cernadas George R. Washko Kathleen J. Haley Juan Carlos Cardet Melody G. Duvall Victoria E. Forth Meghan Le Eva Fandozzi Allison F. O’Neill Katarina Gentile Maria Cinelli Abigail Tulchinsky Guilberto Lawrance Randall Czajkowski Peter Lemole William Antunes Ann D. McGinnis Kris Klokeid Wanda Phipatanakul William J. Sheehan Lisa Bartnikas Sachin N. Baxi Elena Crestani Brittany Etsy Jonathan M. Gaffin Marissa Hauptman David Kantor Peggy S. Lai Margee Louisias Kyle A. Nelson Perdita Permaul Lynda C. Schneider Lakiea S. Wright Samantha Minnicozzi Michelle C. Maciag Mehtap Haktanir-Abul Sigfus Gunnlaugsson Elizabeth Burke‐Roberts Amparito Cunningham Ethan Ansel-Kelly Sullivan Waskosky Anna Ramsey Laura Feloney Sally E. Wenzel Merritt L. Fajt Juan C. Celedón Allyson Larkin Y. Peter Di Hong Wei Chu Marc Gauthier Wei Wu S. Jain Matthew Camiolo Christine Rauscher Faith S. Luyster Paul Rebovich Jessa Demas Renee Wunderley Catherine A. Vitari Melissa Ilnicki Diane Srollo Crystal Takosky Rose Lanzo Joseph K. Leader Daniel M. Lapic Emily Etling Donna H. Rhodes

Background Clustering key clinical characteristics of participants in the Severe Asthma Research Program (SARP), a large, multicenter prospective observational study patients with asthma and healthy controls, has led to identification novel phenotypes. Purpose To determine whether quantitative CT (qCT) could help distinguish between Materials Methods A retrospective cross-sectional analysis was conducted use qCT images (maximal bronchodilation at total lung capacity [TLC], or inspiration,...

10.1148/radiol.210363 article EN Radiology 2022-04-26

Bulk expression data from heterogeneous cell populations pose a challenge for investigators, as differences in numbers and transcriptional programs may complicate analysis. To improve the performance of bulk RNA sequencing on mixed populations, we created Immune Cell Linkage through Exploratory Matrices (ICLite). The ICLite package R constructs modules correlated genes identifies their relationship to specific lineages populations. This protocol details formatting, optimization run...

10.1016/j.xpro.2021.100847 article EN cc-by-nc-nd STAR Protocols 2021-09-27

<p>Supplementary Figure S1. Senescence-activated SASP enhancers are marked by H3K4Me1 in proliferating IMR90 cells. Supplementary S2. Reproducibility analyses of biological replicates for H3K27Ac and BRD4 ChIP-Seq. S3. Enhancer remodeling during oncogene-induced senescence parallels gene expression changes. S4. Genetic pharmacologic inhibition impairs (OIS). S5. couples enhancer to etoposide-induced senescence. S6. Systemic cell-autonomous suppression Brd4 the immune surveillance...

10.1158/2159-8290.22531508.v1 preprint EN cc-by 2023-04-03
Coming Soon ...